Old Web
English
Sign In
Acemap
>
authorDetail
>
Hy Lim
Hy Lim
Medicine
Hepatocellular carcinoma
Oncology
Internal medicine
Diabetes mellitus
3
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial
2020
M. Kudo
Hy Lim
A-L Cheng
Yee Chao
Tcc Yau
S. Ogasawara
M. Kurosaki
N. Morimoto
K. Ohkawa
T. Yamashita
Kh Lee
Erluo Chen
AB Siegel
Baek-Yeol Ryoo
Show All
Source
Cite
Save
Citations (4)
PO-0845 Acute Necrotising Encepholopathy In Childhood – Epidemiology, Radiological Findings And Outcomes
2014
Archives of Disease in Childhood
Hy Lim
V. Ho
Terrence Thomas
Ws Chan
Show All
Source
Cite
Save
Citations (1)
Sorafenib treatment and safety profile in Child Pugh B patients characterized in first interim results of GIDEON (global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib)
2011
Zeitschrift Fur Gastroenterologie
Jean-Pierre Bronowicki
Hy Lim
Per Stål
Jm Marrero
Masatoshi Kudo
Alan P. Venook
Keiko Nakajima
Sheng Long Ye
Show All
Source
Cite
Save
Citations (3)
1